February: A Critical Look at Preventable Cancers and Proactive Health Strategies
admin February marks National Cancer Prevention Month, a dedicated period for the United States to underscore...
biotech
FDA Revolutionizes Product Safety Monitoring with Unified Surveillance Dashboard, Consolidating Disparate Systems for Enhanced Utility and Efficiency
The U.S. Food and Drug Administration (FDA) has announced a significant overhaul of its product...
A Beacon of Hope: How Immunotherapy Transformed the Battle Against Rare Ampullary Cancer for Adrienne Skinner
Adrienne Skinner’s journey from a grim prognosis of rare, stage 4 ampullary cancer to a...
Eli Lilly Urges FDA to Recall Compounded Zepbound, Citing "Dangerous" Impurities and "Unknown Risks" in Unauthorized Formulations
Eli Lilly has intensified its campaign against compounded versions of its blockbuster obesity drug Zepbound...
FDA Streamlines Biosimilar Approval Pathway to Boost Competition and Lower Drug Costs
The U.S. Food and Drug Administration (FDA) has announced significant draft guidance aimed at accelerating...
Cancer in 2026: How Immunotherapy Is Reshaping the Odds
The American Cancer Society’s (ACS) highly anticipated Cancer Statistics 2026 report paints a compelling picture...
Biopharma Sector Navigates Layoffs, Regulatory Hurdles, and Clinical Breakthroughs as Companies Adapt to Evolving Market Dynamics
The biopharmaceutical landscape is currently characterized by a complex interplay of strategic restructurings, significant workforce...
The Alarming Rise of Colorectal Cancer in Younger Adults Demands Immediate Attention and Proactive Measures
Colorectal cancer (CRC), once primarily associated with older age, is experiencing an alarming surge among...
GSK’s Arexvy Secures Expanded FDA Approval for Younger Adults with High-Risk Conditions, Marking a Pivotal Win in a Challenging Regulatory Landscape
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for GSK’s respiratory...
FDA Clears First-of-Its-Kind Allogeneic Stem Cell Therapy for Epilepsy Human Trials, Signifying a Global Biotech Shift
The U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance for...